The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility-Advances in Geriatric Medicine and Research-CSCIED科技核心评价数据库-手机版

The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility

The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility

ES评分 0 浏览量：772 下载量：0

DOI	10.20900/agmr20190008
刊名	Advances in Geriatric Medicine and Research AGMR
年，卷(期)	2019, 1(2)
作者	Brian C. Clark*,Adam J. Woods,Leatha A. Clark,Cody R. Criss,Reza Shadmehr,Dustin R. Grooms,
作者单位	1 Ohio Musculoskeletal and Neurological Institute (OMNI), Ohio University, Athens, OH 45701, USA; 2 Department of Biomedical Sciences, Ohio University, Athens, OH 45701, USA; 3 Division of Geriatric Medicine, Ohio University, Athens, OH 45701, USA; 4 Center for Cognitive Aging and Memory, Department of Clinical and Health Psychology, University of Florida, Gainesville, FL 32610, USA; 5 Heritage Fellow, Translational Biomedical Science Program, Ohio University, Athens, OH 45701, USA; 6 Laboratory for Computational Motor Control, Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MA 21218, USA; 7 Division of Athletic Training, School of Applied Health Sciences and Wellness, College of Health Sciences and Professions, Ohio University, Athens, OH 45701, USA
Abstract	The capacity to move is essential for independence and declines with age. Limitations in mobility impact ~35% of adults over 70 and the majority of adults over 85. These limitations are highly associated with disability, dependency, and survival. More than 25-years ago the term “sarcopenia” was coined to highlight the age-related loss of muscle mass and strength with the assumption being that sarcopenia led to limitations in mobility. However, contrary to expectations, recent findings clearly indicate these variables only modestly explain limitations in mobility. One likely reason the current sarcopenia variables of muscle mass and strength do not discriminate, or predict, mobility limitations well is because they are heavily influenced by musculoskeletal mechanisms and do not incorporate measures reflective of the central neural control of mobility. Unfortunately, the precise central neural changes associated with aging that lead to decreased mobility are poorly understood. This knowledge gap has hampered the development of effective interventions for mobility limitations and the subsequent reduction of major functional disability for older adults. Here, we discuss the potential role of the motor control circuit of the dorsal basal ganglia as well as dopaminergic function in age-related reductions in mobility.
KeyWord	gait; dopamine; sarcopenia; dynapenia; neural control; motor control
基金项目
页码	-

参考文献
相关文献

1.Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-8.

2.Cummings SR, Studenski S, Ferrucci L. A diagnosis of dismobility--giving mobility clinical visibility: a Mobility Working Group recommendation. JAMA. 2014;311(20):2061-2.

3.Musich S, Wang SS, Ruiz J, Hawkins K, Wicker E. The impact of mobility limitations on health outcomes among older adults. Geriatric Nursing. 2018;39(2):162-9.

4.Shumway-Cook A, Ciol MA, Yorkston KM, Hoffman JM, Chan L. Mobility limitations in the Medicare population: prevalence and sociodemographic and clinical correlates. J Am Geriatr Soc. 2005;53(7):1217-21.

5.Vermeulen J, Neyens JC, van Rossum E, Spreeuwenberg MD, de Witte LP. Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review. BMC Geriatrics. 2011;11:33.

6.Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc. 2009;57(8):1411-9.

7.Newman AB, Simonsick EM, Naydeck BL, Boudreau RM, Kritchevsky SB, Nevitt MC, et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA. 2006;295(17):2018-26.

8.Gill TM, Allore HG, Hardy SE, Guo Z. The dynamic nature of mobility disability in older persons. J Am Geriatr Soc. 2006;54(2):248-54.

9.Simonsick EM, Newman AB, Visser M, Goodpaster B, Kritchevsky SB, Rubin S, et al. Mobility limitation in self-described well-functioning older adults: importance of endurance walk testing. J Gerontol A. 2008;63(8):841-7.

10.Hardy SE, Kang Y, Studenski SA, Degenholtz HB. Ability to walk 1/4 mile predicts subsequent disability, mortality, and health care costs. J Gen Intern Med. 2011;26(2):130-5.

11.Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127(Suppl. 5):990S-1S.

12.Roubenoff R, Castaneda C. Sarcopenia-understanding the dynamics of aging muscle. JAMA. 2001;286(10):1230-1.

13.Garber K. No longer going to waste. Nat Biotechnol. 2016;34(5):458-61.

14.Bhasin S, Travison TG, Manini TM, Patel S, Pencina KM, Fielding RA, et al. The Position Statements of the Sarcopenia Definition and Outcomes Consortium. Available from: https://fnih.org/sites/default/files/final/pdf/Sarcopenia%20Definition%20and%20Outcomes%20Overview%20manuscript%2003%2026%202019%20SB.pdf. Accessed 2019 Aug 13.

15.Moore M, Barker K. The validity and reliability of the four square step test in different adult populations: a systematic review. Systemat Rev. 2017;6(1):187.

16.Dite W, Temple VA. A clinical test of stepping and change of direction to identify multiple falling older adults. Arch Phys Med Rehabil. 2002;83(11):1566-71.

17.Holtzer R, Epstein N, Mahoney JR, Izzetoglu M, Blumen HM. Neuroimaging of mobility in aging: a targeted review. J Gerontol A. 2014;69(11):1375-88.

18.Sorond FA, Cruz-Almeida Y, Clark DJ, Viswanathan A, Scherzer CR, De Jager P, et al. Aging, the Central Nervous System, and Mobility in Older Adults: Neural Mechanisms of Mobility Impairment. J Gerontol A. 2015;70(12):1526-32.

19.Varma VR, Hausdorff JM, Studenski SA, Rosano C, Camicioli R, Alexander NB, et al. Aging, the Central Nervous System, and Mobility in Older Adults: Interventions. J Gerontol A. 2016;71(11):1451-8.

20.Rosso AL, Studenski SA, Chen WG, Aizenstein HJ, Alexander NB, Bennett DA, et al. Aging, the central nervous system, and mobility. J Gerontol A. 2013;68(11):1379-86.

21.Clark B. The four-square step test is highly associated with mobility in older adults. 2019. Unpublished work.

22.Montero-Odasso M, Verghese J, Beauchet O, Hausdorff JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012;60(11):2127-36.

23.Matthis JS, Yates JL, Hayhoe MM. Gaze and the Control of Foot Placement When Walking in Natural Terrain. Curr Biol. 2018;28(8):1224-33.e5.

24.Bohnen NI, Jahn K. Imaging: What can it tell us about parkinsonian gait? Mov Disord. 2013;28(11):1492-500.

25.Wilson J, Allcock L, Mc Ardle R, Taylor JP, Rochester L. The neural correlates of discrete gait characteristics in ageing: A structured review. Neurosci Biobehav Rev. 2019;100:344-69.

26.Stoessl AJ, Lehericy S, Strafella AP. Imaging insights into basal ganglia function, Parkinson’s disease, and dystonia. Lancet. 2014;384(9942):532-44.

27.Balleine BW, Liljeholm M, Ostlund SB. The integrative function of the basal ganglia in instrumental conditioning. Behav Brain Res. 2009;199(1):43-52.

28.Dudman JT, Krakauer JW. The basal ganglia: from motor commands to the control of vigor. Curr Opin Neurobiol. 2016;37:158-66.

29.Deniau JM, Mailly P, Maurice N, Charpier S. The pars reticulata of the substantia nigra: a window to basal ganglia output. Prog Brain Res. 2007;160:151-72.

30.Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 1990;13(7):254-8.

31.Rinvik E. Demonstration of nigrothalamic connections in the cat by retrograde axonal transport of horseradish peroxidase. Brain Res. 1975;90(2):313-8.

32.Bostan AC, Dum RP, Strick PL. The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci U S A. 2010;107(18):8452-6.

33.Chevalier G, Vacher S, Deniau JM. Inhibitory nigral influence on tectospinal neurons, a possible implication of basal ganglia in orienting behavior. Exp Brain Res. 1984;53(2):320-6.

34.Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 2011;34:441-66.

35.Berardelli A, Rothwell JC, Thompson PD, Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain. 2001;124(Pt 11):2131-46.

36.Buhusi CV, Meck WH. What makes us tick? Functional and neural mechanisms of interval timing. Nat Rev Neurosci. 2005;6(10):755-65.

37.Turner RS, Desmurget M. Basal ganglia contributions to motor control: a vigorous tutor. Curr Opin Neurobiol. 2010;20(6):704-16.

38.Panigrahi B, Martin KA, Li Y, Graves AR, Vollmer A, Olson L, et al. Dopamine Is Required for the Neural Representation and Control of Movement Vigor. Cell. 2015;162(6):1418-30.

39.da Silva JA, Tecuapetla F, Paixao V, Costa RM. Dopamine neuron activity before action initiation gates and invigorates future movements. Nature. 2018;554(7691):244-8.

40.Shadmehr R, Reppert TR, Summerside EM, Yoon T, Ahmed AA. Movement Vigor as a Reflection of Subjective Economic Utility. Trends Neurosci. 2019;42(5):323-336.

41.Sato M, Hikosaka O. Role of primate substantia nigra pars reticulata in reward-oriented saccadic eye movement. J Neurosci. 2002;22(6):2363-73.

42.Yasuda M, Hikosaka O. To Wait or Not to Wait-Separate Mechanisms in the Oculomotor Circuit of Basal Ganglia. Front Neuroanat. 2017;11:35.

43.Kim HF, Amita H, Hikosaka O. Indirect Pathway of Caudal Basal Ganglia for Rejection of Valueless Visual Objects. Neuron. 2017;94(4):920-30 e3.

44.Kawagoe R, Takikawa Y, Hikosaka O. Reward-predicting activity of dopamine and caudate neurons--a possible mechanism of motivational control of saccadic eye movement. J Neurophysiol. 2004;91(2):1013-24.

45.Xu-Wilson M, Zee DS, Shadmehr R. The intrinsic value of visual information affects saccade velocities. Exp Brain Res. 2009;196(4):475-81.

46.Milstein DM, Dorris MC. The influence of expected value on saccadic preparation. J Neurosci. 2007;27(18):4810-8.

47.Opris I, Lebedev M, Nelson RJ. Motor Planning under Unpredictable Reward: Modulations of Movement Vigor and Primate Striatum Activity. Front Neurosci. 2011;5:61.

48.Reppert TR, Lempert KM, Glimcher PW, Shadmehr R. Modulation of Saccade Vigor during Value-Based Decision Making. J Neurosci. 2015;35(46):15369-78.

49.Summerside EM, Shadmehr R, Ahmed AA. Vigor of reaching movements: reward discounts the cost of effort. J Neurophysiol. 2018;119(6):2347-57.

50.Manohar SG, Chong TT, Apps MA, Batla A, Stamelou M, Jarman PR, et al. Reward Pays the Cost of Noise Reduction in Motor and Cognitive Control. Curr Biol. 2015;25(13):1707-16.

51.Yoon T, Geary RB, Ahmed AA, Shadmehr R. Control of movement vigor and decision making during foraging. Proc Natl Acad Sci U S A. 2018;115(44):E10476-85.

52.Wang KS, Smith DV, Delgado MR. Using fMRI to study reward processing in humans: past, present, and future. J Neurophysiol. 2016;115(3):1664-78.

53.Wang C, Xiao Y, Burdet E, Gordon J, Schweighofer N. The duration of reaching movement is longer than predicted by minimum variance. J Neurophysiol. 2016;116(5):2342-5.

54.Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997;275(5306):1593-9.

55.Bayer HM, Glimcher PW. Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron. 2005;47(1):129-41.

56.Sedaghat-Nejad E, Herzfeld DJ, Shadmehr R. Reward Prediction Error Modulates Saccade Vigor. J Neurosci. 2019;39(25):5010-7.

57.Kawagoe R, Takikawa Y, Hikosaka O. Expectation of reward modulates cognitive signals in the basal ganglia. Nat Neurosci. 1998;1(5):411-6.

58.Haith AM, Reppert TR, Shadmehr R. Evidence for hyperbolic temporal discounting of reward in control of movements. J Neurosci. 2012;32(34):11727-36.

59.Kaasinen V, Rinne JO. Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev. 2002;26(7):785-93.

60.Carlsson A, Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm. 1976;38(3-4):271-6.

61.Suhara T, Fukuda H, Inoue O, Itoh T, Suzuki K, Yamasaki T, et al. Age-related changes in human D1 dopamine receptors measured by positron emission tomography. Psychopharmacology. 1991;103(1):41-5.

62.Wang Y, Chan GL, Holden JE, Dobko T, Mak E, Schulzer M, et al. Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse. 1998;30(1):56-61.

63.Rinne JO, Hietala J, Ruotsalainen U, Sako E, Laihinen A, Nagren K, et al. Decrease in human striatal dopamine D2 receptor density with age: a PET study with
[11C]raclopride. J Cereb Blood Flow Metabol. 1993;13(2):310-4.

64.Wong DF, Young D, Wilson PD, Meltzer CC, Gjedde A. Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging. J Cereb Blood Flow Metabol. 1997;17(3):316-30.

65.Antonini A, Leenders KL. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and
[11C]-raclopride. Ann N Y Acad Sci. 1993;695:81-5.

66.Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, et al. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res. 1996;67(1):11-6.

67.Cham R, Studenski SA, Perera S, Bohnen NI. Striatal dopaminergic denervation and gait in healthy adults. Exp Brain Res. 2008;185(3):391-8.

68.Goble DJ, Coxon JP, Van Impe A, Geurts M, Van Hecke W, Sunaert S, et al. The neural basis of central proprioceptive processing in older versus younger adults: an important sensory role for right putamen. Hum Brain Mapp. 2012;33(4):895-908.

69.Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry. 1998;155(3):344-9.

70.Metti AL, Rosano C, Boudreau R, Massa R, Yaffe K, Satterfield S, et al. Catechol-O-Methyltransferase Genotype and Gait Speed Changes over 10 Years in Older Adults. J Am Geriatr Soc. 2017;65(9):2016-22.

71.Rosso AL, Bohnen NI, Launer LJ, Aizenstein HJ, Yaffe K, Rosano C. Vascular and dopaminergic contributors to mild parkinsonian signs in older adults. Neurology. 2018;90(3):e223-9.

72.Cham R, Perera S, Studenski SA, Bohnen NI. Age-related striatal dopaminergic denervation and severity of a slip perturbation. J Gerontol A. 2011;66(9):980-5.

73.Cham R, Perera S, Studenski SA, Bohnen NI. Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults. Gait Posture. 2007;26(4):516-25.

74.Bohnen NI, Muller ML, Kuwabara H, Cham R, Constantine GM, Studenski SA. Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects. J Rehabil Res Dev. 2009;46(8):1045-52.

75.Bilder RM, Volavka J, Lachman HM, Grace AA. The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004;29(11):1943-61.

76.Cacace F, Mineo D, Viscomi MT, Latagliata EC, Mancini M, Sasso V, et al. Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity. Mov Disord. 2017;32(7):1035-46.

77.Hsieh TH, Huang YZ, Rotenberg A, Pascual-Leone A, Chiang YH, Wang JY, et al. Functional Dopaminergic Neurons in Substantia Nigra are Required for Transcranial Magnetic Stimulation-Induced Motor Plasticity. Cereb Cortex. 2015;25(7):1806-14.

78.Ghiglieri V, Pendolino V, Sgobio C, Bagetta V, Picconi B, Calabresi P. Theta-burst stimulation and striatal plasticity in experimental parkinsonism. Exp Neurol. 2012;236(2):395-8.

79.Ko JH, Strafella AP. Dopaminergic neurotransmission in the human brain: new lessons from perturbation and imaging. Neuroscientist. 2012;18(2):149-68.

80.Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain. 2003;126(Pt 12):2609-15.

81.Monte-Silva K, Ruge D, Teo JT, Paulus W, Rothwell JC, Nitsche MA. D2 receptor block abolishes theta burst stimulation-induced neuroplasticity in the human motor cortex. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2011;36(10):2097-102.

82.Di Lazzaro V, Pilato F, Dileone M, Profice P, Oliviero A, Mazzone P, et al. The physiological basis of the effects of intermittent theta burst stimulation of the human motor cortex. J Physiol. 2008;586(16):3871-9.

83.Reppert TR, Rigas I, Herzfeld DJ, Sedaghat-Nejad E, Komogortsev O, Shadmehr R. Movement vigor as a traitlike attribute of individuality. J Neurophysiol. 2018;120(2):741-57.

84.Choi JE, Vaswani PA, Shadmehr R. Vigor of movements and the cost of time in decision making. J Neurosci. 2014;34(4):1212-23.

85.Bargary G, Bosten JM, Goodbourn PT, Lawrance-Owen AJ, Hogg RE, Mollon JD. Individual differences in human eye movements: An oculomotor signature? Vis Res. 2017 Dec;141:157-69.

86.Harris CM, Wolpert DM. Signal-dependent noise determines motor planning. Nature. 1998;394(6695):780-4.

87.Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, et al. Dopaminergic mechanisms of individual differences in human effort-based decision-making. J Neurosci. 2012;32(18):6170-6.

88.Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the “EEfRT”? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009;4(8):e6598.

89.Jung WH, Jang JH, Park JW, Kim E, Goo EH, Im OS, et al. Unravelling the intrinsic functional organization of the human striatum: a parcellation and connectivity study based on resting-state FMRI. PLoS One. 2014;9(9):e106768.

90.Choi EY, Yeo BT, Buckner RL. The organization of the human striatum estimated by intrinsic functional connectivity. J Neurophysiol. 2012;108(8):2242-63.

91.Di Martino A, Scheres A, Margulies DS, Kelly AM, Uddin LQ, Shehzad Z, et al. Functional connectivity of human striatum: a resting state FMRI study. Cereb Cortex. 2008;18(12):2735-47.

92.Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357-81.

93.Felger JC, Treadway MT. Inflammation Effects on Motivation and Motor Activity: Role of Dopamine. Neuropsychopharmacology. 2017;42(1):216-41.

94.Treadway MT. The Neurobiology of Motivational Deficits in Depression–An Update on Candidate Pathomechanisms. Curr Top Behav Neurosci. 2016;27:337-55.

95.Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52(7):1105-13.

96.Wu T, Hallett M, Chan P. Motor automaticity in Parkinson’s disease. Neurobiol Dis. 2015;82:226-34.

97.Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015;23(2):314-22.

98.Fritz S, Lusardi M. White paper: “walking speed: the sixth vital sign”. J Geriatr Phys Ther. 2009;32(2):46-9.

引用本文

Brian C. Clark*,Adam J. Woods,Leatha A. Clark,Cody R. Criss,Reza Shadmehr,Dustin R. Grooms. The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility, Advances in Geriatric Medicine and Research. 2019; 1; (2). https://doi.org/10.20900/agmr20190008.

文献评论

相关学者

相关机构